Castle Biosciences, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
CSTL Company Description
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.
CSTL Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view CSTL Smart Score
Score Breakdown
CSTL Company Description
Show More
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of CSTL by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CSTL's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on CSTL's company Twitter account
WallStreetBets
Number of mentions of CSTL in WallStreetBets Daily Discussion
CSTL News
Recent insights relating to CSTL
CNBC Recommendations
Recent picks made for CSTL stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in CSTL
Corporate Flights
Flights by private jets registered to CSTL
Our Analysis